NIH
ICYMI: NIH Implements Public Access Policy
On July 1, the National Institutes of Health (NIH) adopted their new Public Access Policy in response to the August 2022 memorandum issued by the White House Office of Science and Technology Policy (OSTP). The memorandum requires federal agencies to make peer-reviewed publications, resulting from federal funding, freely available to the public immediately following publication (see previous COSSA coverage). Manuscripts published after July 1 will be required to follow the new guidelines. NIH has developed a website to help researchers with the transition process.
Latest from the White House (July 8)
Additional Guidance on “Gold Standard Science” As previously reported, President Trump issued an executive order (EO) in May on Restoring Gold Standard Science. On June 23, the White House Office of Science and Technology Policy (OSTP) issued a memorandum to federal agencies providing additional guidance on how to comply with the order. Federal agencies are directed to report to OSTP on steps taken to comply with the EO by August 22. A primary criticism of the EO and accompanying guidance has less to do with the order itself—which focuses on reproducibility, transparency, unbiased peer review, and other common research tenets—and more to do with its calling for…
NIH Suspends Gain of Function Research
The National Institutes of Health (NIH) has released a notice to inform the biomedical research community of a termination of funding for gain-of-function research outside of the U.S. and a suspension of funding for any other projects or programs relating to gain-of-function research. Gain-of-function research has been a point of contention for many Congressional Republicans since the COVID-19 pandemic highlighted the research (see previous COSSA coverage). The notice, which was prompted by a guidance to NIH by the White House Office of Science and Technology (OSTP), is in-line with the Administration’s Executive Order (EO) on Improving the Safety and Security of Biological Research,…
EPA Employees Stand Up to Leadership
Following up on the Bethesda Declaration signed by employees from the National Institutes of Health in June, more than 600 employees of the Environmental Protection Agency (EPA) have signed a Declaration of Dissent addressed to EPA Administrator Lee Zeldin. In it, employees raise five primary concerns about actions taken by EPA leadership or the Trump Administration, including: (1) undermining public trust, (2) ignoring scientific consensus to benefit polluters, (3) reversing EPA’s progress in America’s most vulnerable communities, (4) dismantling the Office of Research and Development, and (5) promoting a culture of fear, forcing staff to choose between their livelihood and well-being. Additional details are…
Bhattacharya Defends NIH Budget Request to Senate Appropriators
As the Congressional appropriations process continues, Dr. Jay Bhattacharya, Director of the National Institutes of Health (NIH), was invited to defend the President’s FY 2026 before the Senate Labor, Health and Human Services, Education, and Related Agencies (LHHS) Appropriations subcommittee (see COSSA’s analysis). Under the President’s budget, the NIH would see steep budget cuts and a major restructuring that would reduce the institutes and centers (ICs) from 27 to 8. Throughout the hearing, Bhattacharya fielded questions on the impacts of these proposals on the research community and dismissed concerns, claiming that the proposal is the starting point of a budget…
All Eyes on Indirect Costs
On June 17, Republican leaders of the House Science, Space and Technology Committee sent a letter to the Government Accountability Office (GAO) requesting that the non-partisan “Congressional watchdog” conduct a comprehensive review of the indirect costs associated with federal research funding. The request comes amid increased attention by lawmakers on indirect costs following the Trump Administration’s effort to set a flat 15 percent rate for facilities and administrative (F&A) costs for grants awarded by the National Institutes of Health (NIH), National Science Foundation (NSF), Department of Energy (DOE), NASA, and Department of Defense (see previous coverage). These efforts are currently stalled as a…
Latest from the White House (June 24)
‘Forward Funding’ by NIH the New Norm? As COSSA has been reporting, the Trump Administration released details of its fiscal year (FY) 2026 budget proposal last month (see related article), which not only includes major funding reductions for federal science agencies, but also major shifts in policy. One such shift is how research grants would be funded by the National Institutes of Health (NIH). According to the NIH budget request, the agency plans to “continue the FY 2025 policy of reserving half of NIH funding allocated toward competing research project grant (RPG) awards for awards that fully fund their outyear commitments…
NIH Employees Outline Concerns in ‘Bethesda Declaration’
On June 9, more than 340 scientists and staff at the National Institutes of Health (NIH) issued a statement criticizing their agency’s leadership for politicizing research. The “Bethesda Declaration,” which as of today includes 484 signatories, urges NIH Director Jay Bhattacharya and other leaders to reverse course on budget reductions, workforce terminations, elimination of research related to DEI, undermining of the peer review process, and instituting a blanket 15 percent indirect cost rate, among others. It is exceptionally rare for federally employees to publicly protest and criticize their own agency. In response, an open letter in support of the Bethesda Declaration has…
Welch, Baldwin Host Two-Day Forum to Spotlight How Americans are Harmed by Trump’s HHS Actions
Senators Peter Welch (D-VT) and Tammy Baldwin (D-WI) held a two-day forum to spotlight how Americans are being harmed by the Trump Administration’s mass firings at the Department of Health and Human Services (HHS). This comes after the Senators hosted a similar townhall on Trump and Musk’s Cuts to Cancer and Alzheimer’s Disease Cures (see previous COSSA coverage). During the two-day forum, Sens. Welch and Baldwin invited former federal agencies officials, including Dr. Anne Schuchat, former Principal Deputy Director at the Centers for Disease Control and Prevention (CDC), Ms. Trina Dutta, former Chief of Staff at the Substance Abuse and Mental Health…
Latest from the White House (May 27)
COSSA continues to follow the flurry of executive actions taken by the Trump Administration and the impact those actions are having on the social and behavioral science community. Below are some of the latest developments coming out of the White House. Past updates are available here. DOD Announces 15% Indirect Cost Cap Earlier this month, the Department of Defense (DOD) announced that it will immediately begin imposing a flat 15 percent indirect cost rate on research sponsored by the department. According to the memo, Defense Secretary Pete Hegseth noted that the cap will not be limited to new grants, but that existing awards…
Senate Appropriators Hold Hearing on Biomedical Research: Keeping America’s Edge in Innovation
On April 30, Senate Appropriators held a bipartisan hearing on Biomedical Research: Keeping America’s Edge in Innovation where they invited several witnesses from the scientific community, including Dr. Sudip Parikh, Chief Executive Officer of the American Association for the Advancement of Science (AAAS), Dr. Hermann Haller, President of the Mount Desert Island Biological Laboratory, Dr. Cartier Esham, Executive Director of the Alliance for a Stronger Food and Drug Administration, Dr. Barry Paul Sleckman, Director of the University of Alabama at Birmingham O’Neal Comprehensive Cancer Center, and Emily Stenson, a patient advocate. During the hearing, several members of the committee across the aisle…
NIH Director Bhattacharya Gives First Public Remarks at NIH Council of Councils
On April 21, the National Institutes of Health (NIH) Director Jay Bhattacharya presented his vision for NIH during a meeting of the NIH Council of Councils. The Council consists of approximately 30 members, selected from the various NIH Institute and Center (IC) Advisory Councils, representatives nominated by the Office of the Director program offices, and broad lay representation. It advises the NIH Director on matters related to the policies and activities of the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI). As previously reported by COSSA, Bhattacharya was confirmed as NIH Director in late March. During his first public remarks since being confirmed,…
Senators Baldwin and Welch Host Town Hall on Cuts to Cancer and Alzheimer’s Disease Cures
On March 26, Senators Tammy Baldwin (D-WI) and Peter Welch (D-VT) hosted a Congressional townhall on Trump and Musk’s Cuts to Cancer and Alzheimer’s Disease Cures. The event was held in response to efforts by the Administration to cut funding for the National Institutes of Health (NIH), including major reductions in the NIH workforce. The town hall featured remarks from former NIH Director Dr. Monica Bertagnolli; Dr. Sterling Johnson, University of Wisconsin-Madison Professor and Associate Director of Wisconsin Alzheimer’s Disease Research Center; Dr. Whitney Wharton, Emory University Associate Professor and Alzheimer’s Disease researcher; Dr. Larry Saltzman, former Executive Research Director for…
Senate Confirms Bhattacharya as NIH Director and Kratsios as OSTP Director
On March 26, the Senate voted to confirm Dr. Jay Bhattacharya as the next Director of the National Institutes of Health (NIH) in a 53-47 vote (see previous COSSA coverage). In his confirmation hearing, Dr. Bhattacharya confirmed that he would prioritize chronic disease research over infectious disease research, aligning with Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., as well as investing in cutting edge research. The Senate also confirmed Michael Kratsios as the Director of the White House Office of Science and Technology Policy (OSTP) in a bipartisan 74-25 vote (see previous COSSA coverage). Kratsios served…
House Science Committee Addresses Threats to Federally Funded Research in Hearing
On March 5, the House Science, Space, and Technology (SST) Committee’s Investigations and Oversight Subcommittee held a hearing on Assessing the Threat to U.S. Funded Research. Witnesses included Mr. Jeffrey Stoff, President, Center for Research Security & Integrity; Mr. John F. Sargent Jr., Retired, Specialist in Science and Technology Policy, Congressional Research Service; and Dr. Maria Zuber, E.A. Griswold Professor of Geophysics and Presidential Advisor for Science and Technology Policy, Massachusetts Institute of Technology (MIT). In his opening remarks, Chairman Rich McCormick (R-GA) highlighted the importance of remaining a global leader in scientific research while protecting U.S. research from foreign competitors….
Latest from the White House (March 18)
COSSA continues to follow the flurry of executive actions taken by the Trump Administration and the impact those actions are having on the social and behavioral science community. Below are some of the latest developments coming out of the White House. Past updates are available here. Trump Eliminates Agencies On March 14, President Trump signed an Executive Order (EO), Continuing the Reduction of the Federal Bureaucracy, which eliminates several agencies “to the maximum extent consistent with applicable law,” including the Woodrow Wilson International Center for Scholars in the Smithsonian Institution and the Institute of Museum and Library Services (IMLS), among others. The Woodrow Wilson International Center…
NIH Director Nominee, Dr. Bhattacharya, Voted Through HELP Committee; CDC Nomination Pulled
On March 13, the nomination of Dr. Jay Bhattacharya advanced through the Senate Health, Education, Labor, and Pensions (HELP) Committee in a 12-11 vote along party lines, overcoming the first hurdle for being confirmed as the National Institutes of Health (NIH) Director (see previous COSSA coverage). The next step is a confirmation vote by the full Senate, which has not yet been scheduled. During his confirmation hearing on March 5, Bhattacharya stated an intent to refocus NIH’s research efforts on addressing chronic diseases, aligning with Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr, as well as investing in cutting…
119th Congress: Profile of the Senate Health, Education, Labor, and Pensions Committee
The Senate Health, Education, Labor, and Pensions (HELP) Committee has jurisdiction over health care, education, employment and retirement policies, including authorization of the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), Department of Education, and more. Like all Senate Committees, the leadership of the HELP Committee shifted to Republican-control following the 2024 elections. Senator Bill Cassidy (R-LA) is now serving as Chair and Senator Bernie Sanders (I-VT) as Ranking Member. As Ranking Member in the last Congress, Cassidy indicated his desire to restructure the National Institutes of Health through a series of public comments and…
Latest from the White House (February 18)
As previously reported, the Trump Administration has from day one been issuing a dizzying number of executive actions, some whose legality remain in question. Below are some of the latest developments coming out of the White House. Federal Workforce Last week, as part of an Executive Order on “workforce optimization,” the President’s Office of Personnel Management directed federal agencies to fire “trial and probationary” employees, providing little other guidance on how to do it. Typically, probationary employees are those within 1-3 years of service in their position. Democratic lawmakers and government worker unions are pushing back, arguing the long-term damage that…
Dorothy Fink Chosen to Serve as Acting HHS Secretary; Appoints Matthew Memoli as Acting NIH Director
Dorothy Fink M.D. has been appointed by President Trump to serve as acting Secretary of Health and Human Services (HHS) as confirmation hearings for the presidential nominee for the position, Robert F. Kennedy Jr., continue. Fink previously served as Deputy Assistant Secretary for Women’s Health and Director of the Office on Women’s Health in the Office of the Assistant Secretary for Health (OASH). Shortly after her appointment, Fink tapped Matthew Memoli, M.D., to serve as acting Director of the National Institutes of Health (NIH) as the Senate works to confirm Jay Bhattacharya (see previous COSSA coverage). Memoli, a National Institute of Allergy and…